1. Croda International Plc Results for 6 months to 30 June 2001

2. Summary Restructuring now complete Strong cash generation of £31m Challenging macroeconomic conditions Strong new product pipeline Confident in medium term prospects

3. Summary of continuing operations Sales159.5154.4 Operating profit21.422.3 Interest(3.1)(4.3) Profit before tax18.318.0 EBITDA 29.128.7 20012000 £m £m

4. Statistics 20012000 EPS normalised (p)9.19.7 DPS (p)3.853.75 Interest cover (x)6.85.4 Tax rate (%)35.133.3

5. Exceptional items £m Profit on sale of businesses5.7 Goodwill written back (4.3) Profit on site disposal3.1 _________ Net profit on disposals4.5 __________

6. Turnover change on prior year* Volume Currency Mix/ Total price -0.5% +2.5% +1.5% +3.5% * continuing operations only

7. Sales by destination * 2001 2000 £m%£m% United Kingdom32.22032.421 Rest of Europe43.22744.028 Americas50.23247.231 Asia19.31217.211 Rest of World14.6913.69 ______________________________________________________ 159.5100154.4100 ______________________________________________________ * continuing operations only

8. Summary of trading Strong growth in the Far East Americas steady UK and Europe slower Vegetable raw material prices stable Energy costs/climate change levy

9. Oleochemicals trends* SalesTrading profit *continuing operations only

10. Cash flow £m 20012000 Operating cash flow26.419.8 Interest(3.1)(4.3) Dividends(4.0)(4.0) Taxation(2.5)(6.8) __________ _______ Free cash flow16.84.7 Net Capex(9.7)(11.4) Own shares(1.5)(1.8) Disposals/Acquisitions 25.2(2.8) __________ ________ Net cash flow30.8(11.3) __________ ________

11. Working capital Stock reduction/rationalisation in process Increased focus on the issue Improved terms with customers and suppliers

12. ERP initial benefits Better management information Improved stock/order visibility Reduction in local stockholding Implementation costs

13. Strategic & operational progress

14. Health Care progress Provensis project update Natural asthma treatment to be launched 2002 Crohn’s disease - product launch Plant based anticholesteremic

15. New products Venuceane from Sederma Sustainable plant products from the Amazon Developments in non-mammalian gelatin

16. Venuceane A multi-enzyme developed from micro-organisms Derived from hydrothermal vents 2000m below sea level Neutralises toxic oxidants which damage the skin Thermally stable 0-75 degrees C Effectiveness of the active increases with temperature For use in day care, sun care and make up

17. Crodamazon Seeds & nuts collected by locals, not farmed Initial processing in zone of collection Sustainable natural ingredients Source of both active & functional ingredients for skin and hair care

18. Gelatin Move away from mammalian products Fish gelatin acceptance rising rapidly Vegetable gelatins in advanced stage of development High levels of product development

19. Outlook Europe uncertain Strong growth in Far East Singapore operating profits rising Continued efforts on working capital Strong new product pipeline